Milky Way Biotech ApS: Financial statements 2024
CVR: 44005255
Source: annual report 2024, Danish Business Authority
17/04/2023 – 30/04/2024
Milky Way Biotech ApS (CVR 44005255) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -3,979 and a net result of DKK -7,507. Equity in the 2024 report amounted to DKK 32,493. The solvency ratio was 23.7%.
- Gross Profit
- DKK -3,979
- Profit/Loss
- DKK -7,507
- Equity
- DKK 32,493
- Total Assets
- DKK 136,913
- Employees
- 0
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout Milky Way Biotech ApS
Milky Way Biotech ApS is a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2023. The company is under bankruptcy. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company is owned by Szoboszlai Holding ApS and Alzamora Holding ApS. The company has 2 employees (2024). In 2024, the company reported a gross profit of DKK -3,979 and a net result of DKK -7,507. Equity in the 2024 report amounted to DKK 32,493.